About Kylix Bio
Kylix Bio is a private company based in Dover, Delaware, incorporated in 2025 in Delaware. It has reported $850,000 raised in one offering on Form D since January 2026. Its chief executive is Catherine Illingworth.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| Jan 15, 2026 | Jan 26, 2026 | $850,000of $12.0M target | 5 | $170K | OptionsRule 506(b) | Form D ↗ |
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Kylix Bio's Form D filed Jan 26, 2026.
Sources
- SECKylix Bio, Inc. filing history
- CompanyOur Story
- InvestorPraxis portfolio: Kylix Bio

